Product

MBK-01

Aliases

Fecal microbiota transfer

1 clinical trial

2 indications

Indication

Clostridium difficile infection

Indication

Clostridium Difficile Infection

Clinical trial

A Randomised, Controlled, Open-label Phase III Clinical Trial in Patients With Primary or Recurrent Clostridioides Difficile (CD) Infection, to Evaluate the Efficacy and Safety of Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin.

Status: Completed, Estimated PCD: 2023-11-15